Ask AI
ProCE Banner Activity

Mind the Gap: Improving Diagnosis and Timely Treatment of sHTG and FCS in Primary Care Settings

Slideset

Expert-curated slides on managing patients with severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS) in the primary care setting—from recognizing symptoms and diagnosing early to timely management with novel sHTG and FCS therapies.

Released: October 10, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals.

Ionis Pharmaceuticals

Target Audience

This activity is intended for internal medicine and family medicine physicians, nurse practitioners, and physician associates who care for patients with sHTG, including FCS.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the pathophysiological mechanisms and diagnostic criteria of severely elevated triglycerides, including FCS

  • Evaluate the risks of severely elevated triglycerides in patients with FCS and the unmet therapeutic need in this population 

  • Assess the latest clinical safety and efficacy data on new and emerging therapies for sHTG and FCS